MFDS
- Status: likely_approved
🇰🇷 Padcev Ejfv in South Korea
Padcev Ejfv (enfortumab-vedotin) regulatory status in South Korea.
Marketing authorisation
Padcev Ejfv in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Padcev Ejfv approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Padcev Ejfv in South Korea?
Astellas Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.